Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
Authors
Keywords
Phospholipase A<sub>2</sub>, Alzheimer’s disease, Mild cognitive impairment
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 121, Issue 2, Pages 193-200
Publisher
Springer Nature
Online
2013-09-14
DOI
10.1007/s00702-013-1088-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2
- (2013) E.L. Schaeffer et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Correlation between platelet and brain PLA2 activity
- (2013) Leda L. Talib et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- (2012) Leda L. Talib et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- (2011) Evelin L. Schaeffer et al. JOURNAL OF NEURAL TRANSMISSION
- Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways
- (2011) Evelin L. Schaeffer et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Neuroinflammatory processes in Alzheimer’s disease
- (2010) Michael T. Heneka et al. JOURNAL OF NEURAL TRANSMISSION
- Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease
- (2010) Evelin L. Schaeffer et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment
- (2010) Orestes V. Forlenza et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cerebrospinal Fluid Secretory Ca2+-Dependent Phospholipase A2 Activity Is Increased in Alzheimer Disease
- (2009) S. Chalbot et al. CLINICAL CHEMISTRY
- Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment
- (2009) Orestes Vicente Forlenza et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Phospholipases A2 and Inflammatory Responses in the Central Nervous System
- (2009) Grace Y. Sun et al. NEUROMOLECULAR MEDICINE
- Inhibition of phospholipase A2 increases Tau phosphorylation at Ser214 in embryonic rat hippocampal neurons
- (2009) Vanessa J. De-Paula et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Mild cognitive impairment: cognitive screening or neuropsychological assessment?
- (2009) Breno Satler Diniz et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
- (2008) Gérard Lambeau et al. Annual Review of Biochemistry
- Human group III secreted phospholipase A2promotes neuronal outgrowth and survival
- (2008) Seiko Masuda et al. BIOCHEMICAL JOURNAL
- CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education
- (2008) Paula V. Nunes et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Conditioning training and retrieval increase phospholipase A2 activity in the cerebral cortex of rats
- (2008) E. L. Schaeffer et al. JOURNAL OF NEURAL TRANSMISSION
- Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment
- (2008) Peder Buchhave et al. NEUROBIOLOGY OF AGING
- Cognitive training increases platelet PLA2 activity in healthy elderly subjects
- (2008) Leda L. Talib et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme
- (2008) Evelin L. Schaeffer et al. PSYCHOPHARMACOLOGY
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
- (2008) Evelin L. Schaeffer et al. PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search